BRIEF-AstraZeneca Provides Update on Evusheld US EUA
AstraZeneca PLC: * UPDATE ON EVUSHELD US EUA
* TO CONTINUE TO WORK WITH FDA, OTHER HEALTH AUTHORITIES TO COLLECT, ASSESS, SHARE RELEVANT DATA REGARDING EVUSHELD AND SARS-COV-2 VARIANTS * EVUSHELD REMAINS AUTHORISED IN OTHER COUNTRIES WHERE IT IS APPROVED FOR COVID PRE-EXPOSURE PROPHYLAXIS,TREATMENT, INCLUDING EU AND JAPAN Source text for Eikon: Further company coverage:
ALSO READ
-
"Loads more ahead": British High Commission in India hails FTA deal amid Diwali celebrations
-
AI investment cycle may have peaked, Jefferies warns; raises India allocation to 14%
-
EU and India conclude negotiations on EUR 93.5 billion Horizon Europe Programme
-
Quad Navies launch Malabar 2026 multi-domain drills to strengthen Free and Open Indo-Pacific
-
'We stuck to our plan for 60 minutes': Hockey captain Harmanpreet after India clinch record sixth Asian Champions Trophy title
Google News